Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02138292
Title A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Texas Southwestern Medical Center



Digoxin + Trametinib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST